News list last updated on 20/01/2026
41 news
Clinical trials
Published on 10/01/2026
FLIPI24: A Modern Prognostic Model and Clinical Trial Enrichment Tool for Newly Diagnosed Follicular Lymphoma
Matthew J Maurer, Vit K Prochazka, Tarec Christoffer El-Galaly, Christopher R Flowers, Diego Villa, Emmanuel Bachy, Elliot J Cahn, Marguerite Fournier, Melissa C Larson, Caroline E Dietrich, Lasse Hjort Jakobsen, Hervé Ghesquières, Robert Kridel, Maher K Gandhi, Chan Y Cheah, Eliza A Hawkes, John F Seymour, Ciara L Freeman, Michael R Clausen, Björn E Wahlin, Jonathan W Friedberg, Carla Casulo, Thomas M Habermann, Yucai Wang, Loretta J Nastoupil, Peter de Nully Brown, David Belada, Andrea Janíková, Heidi Mocikova, Tomáš Fürst, Pierre Feugier, Hervé Tilly, Corinne Haioun, Andrew J Davies, Guillaume Cartron, Richard Burack, Dai Chihara, Peter Martin, Jonathon B Cohen, Izidore S Lossos, Brad S Kahl, Laurie H Sehn, Karin E Smedby, Gilles Salles, Marek Trneny, Brian K Link, Franck Morschhauser, James R Cerhan
Read more
Clinical trials
Studies on data
Published on 09/01/2026
Genome-wide association study of event-free survival in follicular lymphoma patients treated with front-line immunochemotherapy
Hervé Ghesquières, Youenn Drouet, Susan L Slager, Franck Morschhauser, Edith Julia, Sara Galimberti, Dennis Robinson, Melissa C Larson, Quentin Testard, Bruno Tesson, Jean-François Deleuze, Anne Boland, Emilie Thomas, Christine Lasset, Anne J Novak, Luc Xerri, Stefano Luminari, Aurelie Verney, Camille Laurent, Lisa M Rimsza, Thomas M Habermann, Massimo Federico, Brian K Link, Gilles Salles, James R Cerhan
Read more
Studies on data
Published on 03/12/2025
Large B-cell lymphoma: The LYSA pragmatic guidelines
Pierre Sesques, Guillaume Manson, Sydney Dubois, Francois Xavier Gros, Gabriel Brisou, Clémentine Sarkozy, Sophie Bernard, Estelle Bourbon, Luc Matthieu Fornecker, Eric Durot, Laurent Martin, Catherine Chassagne-Clément, Francisco Llamas Gutierrez, Charlotte Syrykh, Marie-Hélène Delfau-Larue, Salim Kanoun, Laetitia Vercellino, Caroline Bodet-Milin, Haifa Bahri, Jules Zhang Yin, Arthur Dony, Laure Lebras, Marlène Ochmann, Marine Baron, Helène Monjanel, Ronan Le Calloch, Fabien Claves, Youlia Kirova, Christian Gisselbrecht, Stéphanie Guidez, Jean Baptiste Bossard, Roberta Di Blasi, Caroline Delette, Ludovic Fouillet, Maryem Rhomdani, Maya Belhadj, Gilles Crochet, Sandy Amorim, Firas Safa, Laurianne Drieu La Rochelle, Julie Abraham, Catherine Thieblemont, Fabrice Jardin, Robin Noel, Sébastien Bailly, Loic Renaud, Yann Guillermin, Baptiste Delapierre, Sylvain Choquet, Louise Roulin, Sylvain Lamure, Lionel Galicier, Yassine Al Tabaa, Carole Soussain, Romain Guièze, Roch Houot, Benoit Tessoulin
Read more
Events
Studies on data
Published on 17/11/2025
ASH 2025 : oral communication for Dr. Stéphanie CORDEIL
VACARME : Analysis of humoral protection at baseline and after vaccination in patients with refractory/relapsed lymphoma and myeloma treated with CD19 and BCMA CAR T-cells.
Read more
Clinical trials
Events
Published on 17/11/2025
Oral presentation for Dr. Pierre SESQUES at ASH 2025
Outcome of patients with large B-cell lymphoma relapsing after second-line CAR-t: Insights from the descar-t registry
Read more
Clinical trials
Published on 17/11/2025
HLA diversity is associated with TKI response and treatment-free remission in chronic myeloid leukemia
Charles Toulemonde, Valérie Dubois, Christophe Bouvier, Alexandre Ridao, Marie-Claire Archier, Marie Balsat, Sophie Ducastelle, Fiorenza Barraco, Gaelle Fossard, Julie Hildt, Julien Bollard, Mauricette Michallet, Hélène Labussière-Wallet, Sandrine Hayette, Franck-Emmanuel Nicolini, Vincent Alcazer
Read more
Events
Studies on data
Published on 17/11/2025
Dr. Vincent Alcazer will present an oral communication at ASH 2025
Presentation ID 76 : A machine learning approach identifies a transcriptomic signature predicting treatment-free remission in chronic myeloid leukemia.
Read more
Events
Published on 04/11/2025
SAVE THE DATE Post-regional ASH: March 6, 2026
Provisional program, subject to change:
9:00 AM: Welcome of participants: Prof. Bachy, Dr. Golfier
9:15 AM: Updates in allogeneic transplantation: Dr. Labussière, Prof. Bay, Dr. Cornillon
9:45 AM: Updates in AML and ALL: Dr. Heiblig, Dr. Carre, Dr. Balsat
Coffee break
11:15 AM: Updates in myelodysplastic syndromes: Dr. Fossard, Prof. Park
11:45 AM: Updates in lymphomas: Prof. Ghesquieres, Dr. Carras, Dr. Sesques, Dr. Fouillet
Lunch break
2:00 PM: Updates in benign hematology: Prof. Garban
2:15 PM: Updates in PNH, aplasias, and myeloproliferative syndromes: Dr. Alcazer, Dr. Barraco
3:15 PM: Updates in multiple myeloma: Dr. Karlin, DR. Lazareth, DR. Chalayer
Coffee Break
3:45 PM: News in the LLC: Prof. Guiez, Dr. Ferrant
4:15 PM: Conclusions and Acknowledgments: Prof. Bachy